Prevention of renal damage caused by Shiga toxin type 2: Action of Miglustat on human endothelial and epithelial cells

Toxicon

Volumn 105, Issue , 2015, Pages 27-33

  Girard, Magalí C ^a   Sacerdoti, Flavia ^a   Rivera, Fulton P ^a   Repetto, Horacio A ^b   Ibarra, Cristina ^a   Amaral, María M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

Author keywords

Hemolytic uremic syndrome; Human glomerular endothelial cells; Immortalized human proximal tubule epithelial cells; Miglustat; Shiga toxin type 2

Indexed keywords

CERAMIDE GLUCOSYLTRANSFERASE; MIGLUSTAT; RECEPTOR; SHIGA TOXIN RECEPTOR; UNCLASSIFIED DRUG; VEROTOXIN 2; 1 DEOXYNOJIRIMYCIN; SHIGA TOXIN;

ARTICLE; ASSAY; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; GLOMERULAR ENDOTHELIAL CELL; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; IN VIVO STUDY; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; ANALOGS AND DERIVATIVES; CELL CULTURE; DRUG EFFECTS; ENDOTHELIUM; EPITHELIUM; KIDNEY;

1-DEOXYNOJIRIMYCIN; CELLS, CULTURED; ENDOTHELIUM; EPITHELIUM; HUMANS; KIDNEY; SHIGA TOXIN;

EID: 84940996699     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2015.08.021     Document Type: Article

References (36)

1. A. Abe, S. Gregory, L. Lee, P.D. Killen, R.O. Brady, A. Kulkarni, and J.A. Shayman Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation J. Clin. Invest. 105 2000 1563 1571
2. H. Alobaidy Recent advances in the diagnosis and treatment of niemann-pick disease type C in children: a guide to early diagnosis for the general pediatrician Int. J. Pediatr. 2015 2015 816593
3. M.M. Amaral, F. Sacerdoti, C. Jancic, H.A. Repetto, A.W. Paton, J.C. Paton, and C. Ibarra Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cells PLoS One 8 2013 e70431
4. E. Bieberich, B. Freischutz, M. Suzuki, and R.K. Yu Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells J. Neurochem. 72 1999 1040 1049
5. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can. J. Biochem. Physiol. 37 1959 911 917
6. V.P. Creydt, C. Silberstein, E. Zotta, and C. Ibarra Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells Microbes Infect. 8 2006 410 419
7. C. Dulsat, and N. Mealy Gaucher's disease Drugs Future 34 2009
8. M.E. Fraser, M. Fujinaga, M.M. Cherney, A.R. Melton-Celsa, E.M. Twiddy, A.D. O'Brien, and M.N. James Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7 J. Biol. Chem. 279 2004 27511 27517
9. M. Jacewicz, H. Clausen, E. Nudelman, A. Donohue-Rolfe, and G.T. Keusch Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide J. Exp. Med. 163 1986 1391 1404
10. M.A. Karmali, M. Petric, C. Lim, P.C. Fleming, G.S. Arbus, and H. Lior The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli J. Infect. Dis. 151 1985 775 782
11. D. Karpman Haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura Curr. Paediatr. 12 2002 569 574
12. D. Karpman, A. Hakansson, M.T. Perez, C. Isaksson, E. Carlemalm, A. Caprioli, and C. Svanborg Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies Infect. Immun. 66 1998 636 644
13. T. Kolter, R.L. Proia, and K. Sandhoff Combinatorial ganglioside biosynthesis J. Biol. Chem. 277 2002 25859 25862
14. C.R. Laing, Y. Zhang, M.W. Gilmour, V. Allen, R. Johnson, J.E. Thomas, and V.P. Gannon A comparison of shiga-toxin 2 bacteriophage from classical enterohemorrhagic Escherichia coli serotypes and the German E. coli O104:H4 outbreak strain Plos One 7 2012 e37362
15. L. Lee, A. Abe, and J.A. Shayman Improved inhibitors of glucosylceramide synthase J. Biol. Chem. 274 1999 14662 14669
16. C.A. Lingwood Role of verotoxin receptors in pathogenesis Trends Microbiol. 4 1996 147 153
17. K.A. McEachern, J. Fung, S. Komarnitsky, C.S. Siegel, W.L. Chuang, E. Hutto, J.A. Shayman, G.A. Grabowski, J.M. Aerts, S.H. Cheng, D.P. Copeland, and J. Marshall A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease Mol. Genet. Metab. 91 2007 259 267
18. S. McGinn, P. Poronnik, E.D. Gallery, and C.A. Pollock A method for the isolation of glomerular and tubulointerstitial endothelial cells and a comparison of characteristics with the human umbilical vein endothelial cell model Nephrology (Carlton) 9 2004 229 237
19. D.O. Moon, S.R. Choi, C.M. Lee, G.Y. Kim, H.J. Lee, and Y.M. Park Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB J. Korean Med. Sci. 20 2005 548 554
20. D.O. Moon, C.Y. Jin, J.D. Lee, Y.H. Choi, S.C. Ahn, C.M. Lee, S.C. Jeong, Y.M. Park, and G.Y. Kim Curcumin decreases binding of Shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-alpha and IL-1beta: suppression of p38, JNK and NF-kappaB p65 as potential targets Biol. Pharm. Bull. 29 2006 1470 1475
21. T.G. Obrig Escherichia coli shiga toxin mechanisms of action in renal disease Toxins (Basel) 2 2010 2769 2794
22. T.G. Obrig, C.B. Louise, C.A. Lingwood, B. Boyd, L. Barley-Maloney, and T.O. Daniel Endothelial heterogeneity in Shiga toxin receptors and responses J. Biol. Chem. 268 1993 15484 15488
23. A. Pellizzari, H. Pang, and C.A. Lingwood Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content Biochemistry 31 1992 1363 1370
24. L. Pianciola, I. Chinen, M. Mazzeo, E. Miliwebsky, G. Gonzalez, C. Muller, C. Carbonari, M. Navello, E. Zitta, and M. Rivas Genotypic characterization of Escherichia coli O157:H7 strains that cause diarrhea and hemolytic uremic syndrome in Neuquen, Argentina Int. J. Med. Microbiol. 304 2014 499 504
25. F.M. Platt, G.R. Neises, R.A. Dwek, and T.D. Butters N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis J. Biol. Chem. 269 1994 8362 8365
26. F.M. Platt, G. Reinkensmeier, R.A. Dwek, and T.D. Butters Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycin J. Biol. Chem. 272 1997 19365 19372
27. S. Porubsky, G. Federico, J. Muthing, R. Jennemann, N. Gretz, S. Buttner, N. Obermuller, O. Jung, I.A. Hauser, E. Grone, H. Geiger, H.J. Grone, and C. Betz Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure J. Pathol. 234 2014 120 133
28. H.A. Repetto Epidemic hemolytic-uremic syndrome in children Kidney Int. 52 1997 1708 1719
29. M. Rivas, E. Miliwebsky, I. Chinen, N. Deza, and G.A. Leotta The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission Medicina (B Aires) 66 Suppl. l3 2006 27 32
30. M. Rivas, E. Miliwebsky, I. Chinen, C.D. Roldan, L. Balbi, B. Garcia, G. Fiorilli, S. Sosa-Estani, J. Kincaid, J. Rangel, and P.M. Griffin Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina Foodborne Pathog. Dis. 3 2006 88 96
31. K. Sandvig, M. Ryd, O. Garred, E. Schweda, P.K. Holm, and B. van Deurs Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP J. Cell. Biol. 126 1994 53 64
32. C.D. Silbertsein C, W.L. Chiang, H.A. Repetto, and C. Ibarra A glucosylceramide synthase inhibitor prevents the cytotoxic effects of shiga toxin-2 on human renal tubular epithelial cells J. Epithel. Biol. Pharmacol. 1 2008 71 75
33. P.I. Tarr, C.A. Gordon, and W.L. Chandler Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome Lancet 365 2005 1073 1086
34. V.L. Tesh Activation of cell stress response pathways by Shiga toxins Cell Microbiol. 14 2012 1 9
35. A. Treiber, O. Morand, and M. Clozel The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor miglustat in the rat Xenobiotica 37 2007 298 314
36. H. Zhao, M. Przybylska, I.H. Wu, J. Zhang, C. Siegel, S. Komarnitsky, N.S. Yew, and S.H. Cheng Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes Diabetes 56 2007 1210 1218